Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Value Health. 2020 Mar 19;23(5):551–558. doi: 10.1016/j.jval.2020.01.018

Figure 1.

Figure 1.

Timing of payer adoption of positive coverage for NGTS Note. Adopters, payers who adopted positive coverage for NGTS on or before 04/01/2019 for any indication, any NGTS test(s) and any policy stipulation (eg, with or without prior authorization); N = 33, total number of payers who adopted a positive coverage for NGTS on or before 04/01/2019. Green circles denote payers with less than 1 000 000 commercial enrollees. Purple circles denote payers with 1 000 000 or more commercial enrollees.

NGTS indicates next-generation tumor sequencing.